CalciMedica: director Alan Glicklich received 20,000 shares

What happened Alan Glicklich, director, received an award of 20,000 derivative shares on Oct 1, 2026. The grant is listed at $0.00 per share, total $0.

Key details

• Transaction date and code: Oct 1, 2026; code A (award/grant).
• Price: $0.00 per share; total value reported $0.
• Shares owned after the transaction: not reported in this Form 4.
• Footnote: beginning Aug 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over one year; option will be fully vested on the date of the 2027 annual meeting of stockholders (footnote F1).
• Filing date: Oct 5, 2026. The filing does not indicate a late filing code.

Why it may matter

• This Form 4 reports a grant of derivative securities (an award), not a market sale or purchase.
• The grant is subject to a vesting schedule described in the footnote.
• A filing does not show why the insider traded or why the company acted.